ReviewBMJ (Clinical research ed.)2004
Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.
Review in BMJ (Clinical research ed.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis.BMC nephrology · 2017Pooled it
- Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.PLoS medicine · 2011Pooled it
- The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.BMJ (Clinical research ed.) · 2004Pooled it
- A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.Annals of the rheumatic diseases · 2005Trial
- Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses.Systematic reviews · 2023Article
- Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease.Journal of the American Geriatrics Society · 2017Article
- Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014Article
- Special considerations with the use of intravenous immunoglobulin in older persons.Drugs & aging · 2011Review
- The role of tramadol in current treatment strategies for musculoskeletal pain.Therapeutics and clinical risk management · 2007Article
- European Medicines Agency policies for clinical trials leave women unprotected.Journal of epidemiology and community health · 2006Article
- Complicity theory: an explanation for the 'coxib problem'?Journal of the Royal Society of Medicine · 2006Article
- Evaluating medical effectiveness for the california health benefits review program.Health services research · 2006Article
- Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.BMJ (Clinical research ed.) · 2005Article
- Lessons from the withdrawal of rofecoxib.BMJ (Clinical research ed.) · 2004Article
- Balancing benefits and harms in health care: ethical dimension was not discussed in theme issue.BMJ (Clinical research ed.) · 2004Article
- Balancing benefits and harms in health care: technology to collect and share information about harms already exists.BMJ (Clinical research ed.) · 2004Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.